Servana AB (XSAT:SERV) Pretax Margin %: -973.33% (As of Mar. 2026)


What is Servana AB Pretax Margin %?

Servana AB XSAT:SERV Pretax Margin % is -973.33% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Servana AB ranks worse than 97.06% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Servana AB's Pre-Tax Income for the three months ended in Mar. 2026 was kr-0.15 Mil. Servana AB's Revenue for the three months ended in Mar. 2026 was kr0.02 Mil. Therefore, Servana AB's pretax margin for the quarter that ended in Mar. 2026 was -973.33%.

The historical rank and industry rank for Servana AB's Pretax Margin % or its related term are showing as below:

XSAT:SERV' s Pretax Margin % Range Over the Past 10 Years
Min: -516800   Med: -1529.25   Max: -308.49
Current: -5282.54


XSAT:SERV's Pretax Margin % is ranked worse than
97.06% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: 2.4 vs XSAT:SERV: -5282.54

Servana AB  (XSAT:SERV) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Servana AB Pretax Margin % Related Terms


Servana AB Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Servana AB's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Servana AB Pretax Margin % Chart

Servana AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,529.25 -745.79 -392.89 -308.49 -6,650.00

Servana AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.30 -69,225.00 -2,716.67 -657.89 -973.33

XSAT:SERV vs ISRG, BDX, MDLN: Pretax Margin % Comparison

For the Medical Instruments & Supplies subindustry, Servana AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Servana AB Pretax Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Servana AB's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Servana AB's Pretax Margin % falls into.



Servana AB Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Servana AB's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.192/0.048
=-6,650.00 %

Servana AB's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.146/0.015
=-973.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -973.33% mean?
Servana AB (XSAT:SERV) has a Pretax Margin % of -973.33% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Servana AB and its competitors. According to the industry distribution chart, Servana AB ranks #793 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 97.1%.
Is Servana AB's Pretax Margin % too high?
Servana AB's current Pretax Margin % is -973.33%. Based on the distribution chart, Servana AB ranks #793 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Servana AB's Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Servana AB ranks #793 out of 817 companies for Pretax Margin %. This places Servana AB in the lower half of its industry. The industry median Pretax Margin % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.40, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Servana AB and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Servana AB's current Pretax Margin % is -973.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Servana AB stock overvalued right now?
Based on GuruFocus' analysis, Servana AB (XSAT:SERV) is currently considered Significantly Undervalued. The stock's GF Value™ is kr0.01, compared to a current price of kr0.00 — trading 68% below its estimated fair value. The current Pretax Margin % is -973.33%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Servana AB (XSAT:SERV), the current Pretax Margin % is -973.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Servana AB Business Description

Address Zinkgatan 2, Lomma, SWE, 234 35
Servana AB formerly, Medimi AB is engaged in the development, production, and marketing of medication products. It offers Medimi Pro and Medimi Smart computerized pill dispensers that are used by patients, consumers, and healthcare staff to follow their drug schedule. The company focus on the following market segments namely Pharmaceutical industry, Hospital and retirement homes, Home Health Care, Pharmacy and private care, and Connected Health (Telemedicine), E-Health and Integration in Other Systems.